Pages
Products

Panoply™ Human EPRS Knockdown Stable Cell Line

For research use only. Not intended for any clinical use.

Cat. No. :   CSC-DC005011

Host Cell :   HEK293 (Hela and other cell types are also available) Validation :   Real-Time RCR

Inquire for Price

Cell Line Information

Safety and Packaging

Gene Information

Cat. No. CSC-DC005011
Description Creative Biogene's Knockdown Cell Lines are target specific shRNA lentivirus transduced cells. The percent knockdown levels range from 75-99% depending on the gene, as evaluated by Real-Time RCR. Cells are rigorously qualified and mycoplasma free.
Target Gene EPRS
Host Cell HEK293 (Hela and other cell types are also available)
Host Cell Species Homo sapiens (Human)
Applications

(1) Studying gene functions

(2) Studying gene interactions and signaling pathways

(3) Target validation and drug discovery

(4) Designing diseases models

Size >1 × 106 cells / vial
Stability Validated for at least 10 passages
Validation Real-Time RCR
Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Storage Liquid Nitrogen
Shipping Dry Ice
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations The following safety precautions should be observed.
1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.
2. No eating, drinking or smoking while handling the stable line.
3. Wash hands after handling the stable line and before leaving the lab.
4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.
5. All waste should be considered hazardous.
6. Dispose of all liquid waste after each experiment and treat with bleach.
Ship Dry ice
Gene Name EPRS glutamyl-prolyl-tRNA synthetase [ Homo sapiens ]
Gene Symbol EPRS
Synonyms EARS; PARS; QARS; QPRS; PIG32; GLUPRORS
Gene Description glutamyl-prolyl-tRNA synthetase
Gene ID 2058
Uni Prot ID P07814
m RNA Refseq NM_004446.2
Protein Refseq NP_004437.2
Chromosome Location 1q41
Function ATP binding; RNA binding; glutamate-tRNA ligase activity; proline-tRNA ligase activity; protein binding;
Pathway Aminoacyl-tRNA biosynthesis, organism-specific biosystem; Aminoacyl-tRNA biosynthesis, conserved biosystem; Aminoacyl-tRNA biosynthesis, eukaryotes, organism-specific biosystem; Aminoacyl-tRNA biosynthesis, eukaryotes, conserved biosystem; Cytosolic tRNA aminoacylation, organism-specific biosystem; Gene Expression, organism-specific biosystem; Porphyrin and chlorophyll metabolism, organism-specific biosystem;
MIM 138295
Quick Inquiry

Case Study

Q & A

Customer Reviews

Host factor tRNA contributes to the replication of retroviruses such as human immunodeficiency virus type 1 (HIV-1). HIV-1 utilizes human tRNALys3 as a primer for reverse transcription, and the assembly of HIV-1 structural protein Gag at the plasma membrane (PM) is regulated by the interaction of its matrix (MA) domain with tRNA. A large, dynamic multi-aminoacyl-tRNA synthetase complex (MSC) exists in the cytoplasm, composed of eight aminoacyl-tRNA synthetases (ARS) and three other cellular proteins. Proteomic studies aimed at identifying interactions between HIV and the host have shown that the MSC is part of the HIV-1 Gag and MA interactome. Here, researchers confirmed that the MA domain of HIV-1 Gag forms a stable complex with the MSC and localized the main interaction site to the linker domain of the bifunctional human glutamyl-prolyl-tRNA synthetase (EPRS), and showed that the MA-EPRS interaction is RNA-dependent. MA mutations that significantly reduce EPRS interaction decrease viral infectivity, and these mutation sites are located on MA residues that interact with phosphatidylinositol-(4,5)-bisphosphate. Overexpression of EPRS or EPRS fragments does not affect susceptibility to HIV-1 infection, while EPRS knockdown reduces the translation of both control reporter genes and HIV-1 proteins. EPRS knockdown leads to a decrease in progeny virus particle production, but this decrease cannot be attributed to a selective effect on viral gene expression, and the specific infectivity of the virus particles remains unchanged.

To further investigate the effect of EPRS on HIV-1 gene expression, researchers infected HEK293T cells overexpressing full-length EPRS or the EPRS linker domain with HIV-Luc/VSV-G virus and measured luciferase activity 24 hours post-infection. The results showed no significant difference in luciferase activity between cells overexpressing full-length EPRS or the EPRS linker domain compared to the control group using the vector alone (Figure 1A). To determine the effect of EPRS knockdown on HIV-1 gene expression, researchers constructed stable EPRS knockdown HEK293T cell lines and infected these cells with HIV-Luc/VSV-G virus encoding firefly (FF) luciferase (Figure 1B). As an internal control, cells were simultaneously transfected with a vector encoding Renilla luciferase (pRL-TK), driven by the HSV thymidine kinase (TK) promoter. In EPRS knockdown cells, HIV-1 gene expression (represented by FF luciferase activity) was reduced fourfold, and a similar reduction was observed in non-HIV gene expression (represented by Renilla luciferase activity) (Figure 1C, D). After normalizing FF luciferase activity to Renilla luciferase activity, HIV-1 gene expression levels were similar in EPRS knockdown cells and control cells (Figure 1E), indicating that the negative effect of EPRS knockdown on gene expression was not HIV-specific. FF luciferase mRNA levels were not different between EPRS knockdown cells and control cells, suggesting that EPRS does not specifically affect the transcription of HIV-1 genes (Figure 1F). Instead, EPRS knockdown affected the translation of FF luciferase, likely due to its overall effect on tRNA aminoacylation.

Figure 1. Effect of EPRS on HIV-1 gene expression.Figure 1. Effect of EPRS on HIV-1 gene expression. (Jin D, et al., 2023)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction